Evidence map›Paper›PMID 31602186›Full record

ArticleCurrent urology2019

Influence of the Body Mass Index and its Effect on Tumor Characteristics and Survival among a Population with Access to Surgical Management of Upper Tract Urothelial Carcinoma.

Teruo Inamoto, Naoto Sassa, Ryohei Hattori, Naokazu Ibuki, Kazumasa Komura, Koichiro Minami, Tomoaki Takai, Taizo Uchimoto, Kenkichi Saito, Naoki Tanda and 6 more

Abstract read
In one paragraph

Article in Current urology, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors.

Teruo InamotoDepartment of Urology, Osaka Medical College, Osaka.
Naoto SassaDepartment of Urology, Nagoya University Graduate School of Medicine.
Ryohei HattoriDepartment of Urology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya.
Naokazu IbukiDepartment of Urology, Osaka Medical College, Osaka.
Kazumasa KomuraDepartment of Urology, Osaka Medical College, Osaka.
Koichiro MinamiDepartment of Urology, Osaka Medical College, Osaka.
Tomoaki TakaiDepartment of Urology, Osaka Medical College, Osaka.
Taizo UchimotoDepartment of Urology, Osaka Medical College, Osaka.
Kenkichi SaitoDepartment of Urology, Osaka Medical College, Osaka.
Naoki TandaDepartment of Urology, Osaka Medical College, Osaka.
Takuya TsujinoDepartment of Urology, Osaka Medical College, Osaka.
Tomoyasu SanoDepartment of Urology, Japanese Red Cross Nagoya Daiichi Hospital, Nagoya.
Masashi KatoDepartment of Urology, Nagoya University Graduate School of Medicine.
Toyonori TsuzukiDepartment of Pathology, Aichi Medical University, Aichi, Japan.
Momokazu GotohDepartment of Urology, Nagoya University Graduate School of Medicine.
Haruhito AzumaDepartment of Urology, Osaka Medical College, Osaka.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo examine the association between the body mass index (BMI) and the risk of survival, and to evaluate whether tumor characteristics differ by BMI in patients with upper tract urothelial carcinoma (UTUC) managed by surgery.

methodsA clinical series on 876 patients with localized UTUC following nephroureterectomy with a bladder cuff, with data from Osaka Medical College registry (discovery cohort) and the Nagoya group (validation cohort) was examined. In addition to analyzing the overall survival and cancer-specific survival (CSS), the survival impact adjusted by pathological variables was also assessed by the BMI group.

resultsThe percentage of high risk features including positive lymphovascular invasion was doubled in the discovery cohort compared to the validation cohort. The group of BMI ≥ 25 kg/m

conclusionsWe found a clinically relevant signature for high risk patients with BMI grouping. Further research is necessary on whether tailoring recommendations for weight and nutrition management to tumor characteristics will improve outcomes.

Indexed as

Body mass indexPrognosisUpper tract urothelial carcinoma

Identifiers

PMID31602186
PMCPMC6738144

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.